{
    "Trade/Device Name(s)": [
        "AutoSure Voice II Blood Glucose Monitoring System",
        "AutoSure Blood Glucose Test Strips"
    ],
    "Submitter Information": "Apex BioTechnology Corp.",
    "510(k) Number": "K102037",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "July 2, 2010",
    "Summary Letter Received Date": "July 19, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AutoSure Voice II Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical glucose measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for AutoSure Voice II Blood Glucose Monitoring System and AutoSure Blood Glucose Test Strips for quantitative measurement of glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood samples from fingertips, forearm, or palm for self-testing by people with diabetes and clinical use by professionals; not indicated for diagnosis or screening of diabetes or for neonatal use.",
    "fda_folder": "Clinical Chemistry"
}